Dr. Bilazarian studies various aspects of heart health, particularly looking at how certain medical devices can improve blood flow in patients undergoing treatments for heart conditions. He investigates the prevalence of metabolic syndrome, a serious cluster of health issues linked to heart disease, especially among younger patients experiencing heart attacks. Additionally, he assesses heart abnormalities in specific patient populations, helping clinicians understand risks and predict outcomes more accurately.
Key findings
In a study on reperfusion sheaths, Dr. Bilazarian found that blood flow rates improved from 167 ml/min to 356 ml/min when using an active pressure system, demonstrating that device configuration is crucial for enhancing blood flow.
In his 2007 research, he revealed that 72% of young heart attack patients undergoing percutaneous coronary intervention had metabolic syndrome, indicating a significant risk factor for future cardiovascular issues.
His study on AL amyloidosis showed that 31% of patients with heart involvement had late electrical signals on tests, compared to 9% of those without heart issues, highlighting the need for closer monitoring of these patients.
Frequently asked questions
Does Dr. Bilazarian study heart conditions?
Yes, he extensively researches various heart conditions and treatments, focusing on improving patient outcomes.
What treatments has Dr. Bilazarian researched?
He has studied the effectiveness of mechanical circulatory support devices and procedures like percutaneous coronary intervention.
Is Dr. Bilazarian's work relevant to young heart attack patients?
Absolutely, his studies reveal significant risk factors like metabolic syndrome that directly impact young patients' heart health.
Publications in plain English
Flow characteristics of reperfusion sheaths when utilizing large bore mechanical circulatory support devices.
2025
Cardiovascular revascularization medicine : including molecular interventions
Aziz IN, Jabri A, Xu Y, Bilazarian S, Bentley D +8 more
Plain English This research looked at how well different medical devices called reperfusion sheaths allow blood to flow when used with large bore support devices. They found that changing the size of these sheaths had little effect on flow rates, with minimal increases observed even with larger sizes—flow rates ranged from 167 ml/min to 179 ml/min as sheath size increased. Importantly, using a specific setup with an active pressure system dramatically increased flow to 356 ml/min, demonstrating that certain configurations can significantly improve blood flow and potentially reduce complications for patients.
Who this helps: This benefits patients undergoing procedures involving mechanical circulatory support, particularly those at risk for limb circulation issues.
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank.
2021
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Naidu SS, Baron SJ, Eng MH, Sathanandam SK, Zidar DA +81 more
Plain English The 2021 Think Tank organized by the Society for Cardiovascular Angiography and Interventions (SCAI) gathered experts in interventional cardiology to discuss important topics across four key areas: treating blocked arteries, endovascular procedures, heart structure issues, and congenital heart defects. The goal of these discussions was to generate ideas and action steps to improve practices in these areas. This matters because advancements in interventional cardiology can lead to better patient outcomes and more effective treatments.
Who this helps: Patients with heart conditions and the doctors treating them.
Letter by Bilazarian et al. regarding the article, "Adverse events and modes of failure related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database" by Khalid et al.
2019
Cardiovascular revascularization medicine : including molecular interventions
Prevalence of metabolic syndrome in patients < or =45 years of age with acute myocardial infarction having percutaneous coronary intervention.
2007
The American journal of cardiology
Chung EH, Curran PJ, Sivasankaran S, Chauhan MS, Gossman DE +7 more
Plain English This study looked at young patients aged 18 to 45 who had heart attacks and were treated with a procedure called percutaneous coronary intervention. Out of 223 patients, 161 (about 72%) were found to have metabolic syndrome, which is a group of health risks linked to heart disease. This is important because it highlights that many young heart attack patients have metabolic syndrome, putting them at greater risk for future health problems.
Who this helps: This information benefits doctors and healthcare providers treating young patients with heart issues.
Signal-averaged electrocardiography in patients with AL (primary) amyloidosis.
1997
American heart journal
Dubrey SW, Bilazarian S, LaValley M, Reisinger J, Skinner M +1 more
Plain English This study examined 133 patients with AL amyloidosis to understand the relationship between heart abnormalities and death risk. Researchers found that 31% of patients with signs of heart involvement from imaging tests had late electrical signals, compared to only 9% of those without heart issues. Out of the group, 106 patients died during the follow-up, highlighting that both abnormal heart tests and late potentials can predict the risk of heart-related deaths.
Who this helps: This information is valuable for doctors treating AL amyloidosis patients, as it helps them identify those at higher risk for sudden cardiac death.